MoneyWorks4Me

Epigral - Quaterly Results

28 Jul 2026 Evaluate
The company witnessed a 16.29% growth in the revenue at Rs. 7053.60 millions for the quarter ended June 2026 as compared to Rs. 6065.40 millions during the year-ago period.The Company to register a -38.17%  fall in the net profit for the quarter ended June 2026.OP of the company witnessed a marginal growth to 1833.00 millions from 1716.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 7053.60 6065.40 16.29 7053.60 6065.40 16.29 25271.80 25501.30 -0.90
Other Income 41.00 82.50 -50.30 41.00 82.50 -50.30 149.80 152.10 -1.51
PBIDT 1833.00 1716.40 6.79 1833.00 1716.40 6.79 5820.50 7259.30 -19.82
Interest 72.20 233.70 -69.11 72.20 233.70 -69.11 719.60 532.70 35.09
PBDT 1760.80 1482.70 18.76 1760.80 1482.70 18.76 5100.90 6726.60 -24.17
Depreciation 429.00 415.40 3.27 429.00 415.40 3.27 1682.90 1325.60 26.95
PBT 1331.80 1067.30 24.78 1331.80 1067.30 24.78 3418.00 5401.00 -36.72
TAX 340.00 -536.80 -163.34 340.00 -536.80 -163.34 87.90 1834.00 -95.21
Deferred Tax -8.10 -790.70 -98.98 -8.10 -790.70 -98.98 -758.70 852.30 -189.02
PAT 991.80 1604.10 -38.17 991.80 1604.10 -38.17 3330.10 3567.00 -6.64
Equity 431.40 431.40 0.00 431.40 431.40 0.00 431.40 431.40 0.00
PBIDTM(%) 25.99 28.30 -8.17 25.99 28.30 -8.17 23.03 28.47 -19.09

Epigral Share Price

1117.40 15.50 (1.41%)
13-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2601.85
BASF India 4132.95
Pidilite Inds. 1686.10
Tata Chemicals 672.20
GNFC 550.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: